iSpecimen (ISPC) Proxy filing summary

Executive summary

• Special meeting convened October 9, 2026; voting on Proposal No. 2 was adjourned to October 30 at 10:00 a.m. ET, with polls left open for that proposal. No other business is scheduled for the adjourned meeting.

• Proposal Nos. 1, 3, 4 and 5 were voted on October 9; the results were reported in an October 9 Form 8-K.

Voting matters and shareholder proposals

• Proposal No. 1 sought approval for warrant-related share issuance under Nasdaq Rule 5635(d), potentially exceeding 19.99% of pre-transaction shares and at a price below Nasdaq’s Minimum Price.

• Proposal No. 3 sought approval for shares tied to potential financing transactions over the 12 months after approval, including securities with conversion or exercise prices discounted up to 80% from the applicable lowest VWAP.

• Proposal No. 4 sought authority to adjourn the meeting, if needed, to solicit additional proxies; Proposal No. 5 sought approval of the Foldlab Al Ltd. asset acquisition and partial share consideration.

• Proposal No. 2 will pass if votes cast FOR exceed votes cast AGAINST; abstentions and shares not voted have no effect. The standard follows DGCL Section 242(d)(2), subject to Nasdaq listing and minimum-holder conditions.

• Voting or revoting on Proposal No. 2 is available online or by phone through October 29, 2026, 11:59 p.m. ET, or during the October 30 virtual meeting; earlier submitted votes remain valid unless revoked.

Board of directors and corporate governance

• The board unanimously recommends voting FOR the reverse stock split proposal.